Today’s Top Story

Make Your Plan to Visit the Exhibit Hall in Las Vegas

Experience the best in orthopaedic technology and innovation in the Exhibit Hall at the AAOS 2023 Annual Meeting. Meet with industry experts and put your hands on the latest cutting-edge products. Extend your education in the Exhibit Hall with a multitude of opportunities available including Ask an Expert, Innovation Theater, Lunch & Learns, TechTalks, and more. This year during Happy Hour in the Hall, industry experts will have special in-booth presentations available for you to learn more about the newest solutions and network.

Learn more about the Exhibit Hall…

 
 
 
 
In Other News

Retrospective Study Investigates Association between Preoperative Corticosteroid Injection and Risk of PJI in RSA

A study in the Journal of Shoulder and Elbow Surgery found that intra-articular corticosteroid shoulder injections (CSIs) <4 weeks presurgery were associated with increased risk of periprosthetic joint infection (PJI) at 90 days and one year after reverse shoulder arthroplasty (RSA). Utilizing a national database, five CSI cohorts were identified: <4 weeks prior (n = 5,607), one to two months prior (n = 3,024), two to three months prior (n = 1,572), >3 months prior (n = 16,302), and no injections presurgery (n = 21,938). There was no significant increase in risk of PJI for patients who received CSI >1 month presurgery.

Read the abstract…

 
 
 
 
Study Compares Outcomes of THA and Hemiarthroplasty in Patients with Femoral Neck Fracture

The Journal of Bone and Joint Surgery published a propensity score-matched study comparing the clinical outcomes of patients undergoing hemiarthroplasty or total hip arthroplasty (THA) for the treatment of femoral neck fractures. A total of 4,612 THA patients were 1:1 matched with a cohort of hemiarthroplasty patients, and the incidence of hip dislocation, revision surgery, readmission, and mortality were compared between groups. THA patients were at an increased risk of hip dislocation after 30 days and one and two years after surgery; however, the risk of mortality was lower after one and two years for THA patients.

Read the abstract…

 
 
 
Study: Is Aragonite-based Scaffold Superior to Microfractures and Debridement for the Treatment of Knee Chondral and Osteochondral Lesions?

In a randomized controlled trial, patients who received an aragonite-based implant for the treatment of knee chondral and osteochondral lesions had statistically better outcomes compared against a control cohort of patients treated with arthroscopic debridement/microfractures. The study was published in American Journal of Sports Medicine. The rate of failure in the implant and control groups were 7.2 percent and 21.4 percent, respectively. After two years, the magnitude of improvement in the implant group was twice as large compared with the control group in regards to mean Knee injury and Osteoarthritis Outcome Scores.

Read the abstract…

 
 
 
 
Study: Outcomes and Costs Associated with Bone Morphogenic Protein Use in Medicare Patients Undergoing Spinal Fusion

According to a retrospective cohort study in the Spine Journal, the use of bone morphogenic protein (BMP) was associated with increased hospital costs but similar Medicare payments in a study population of 316,070 patients who underwent spinal fusion. Analyzing the trends, complications, and costs associated with BMP, the overall rate of BMP utilization decreased from 23.1 percent in 2006 to 12.0 percent in 2015 Additionally, the use of BMP was associated with an overall decrease in complications following thoracic and anterior lumbar fusions; however, there was an increased rate of reoperation in anterior cervical, posterior cervical, thoracic, and posterior lumbar fusions.

Read the abstract…

 
 
 
AAOS Now

Robust Resident Programming Slated for AAOS 2023

At the AAOS 2023 Annual Meeting, attendees at all stages of their careers will experience the exchange of insights, education rooted in the latest practice techniques, state-of-the-art exhibits, and collaboration with a diverse audience of healthcare and industry professionals. Orthopaedic surgery residents can especially benefit from participating in an expansive program developed to meet their unique educational needs and foster a collaborative, fun meeting experience.

Read more…

 
 
 
Your AAOS

Virtual Trauma Course Brought to You by AAOS and the Orthopaedic Trauma Association

On Saturday, April 1, the single-day online course titled “AAOS/OTA Daily Dilemmas in Trauma” will provide the latest updates in orthopaedic trauma. Led by Paul Tornetta III, MD, FAAOS, and J. Tracy Watson, MD, FAAOS, along with 30 renowned faculty, the case-based format delivers insights on fracture fixation (both operative and nonoperative) as well as complication management, outcomes, and more. The interactive live program is comprised primarily of small group case reviews on common yet challenging fractures and traumatic injuries. The virtual package also includes more than 45 prerecorded lectures and access to all content for 60 days.

Register now…